Media Releases › Sienna Cancer Diagnostics

View All Sienna Cancer Diagnostics News


Sienna signs lease for new premises to facilitate the execution of its strategic goal to become an IVD Hub

08 Oct 2019 11:40 AM

  • Sienna advances its plans to become a hub for IVD test development and commercialisation
  • New premises are located near CSIRO and the Monash Technology Precinct
  • New manufacturing facilities for SIEN-NETTM product line to be built
Melbourne, Australia, 8 October 2019: Sienna Cancer Diagnostics Ltd (ASX: SDX) (“Sienna” or “the Company”), a medical technology company developing and commercialising innovative IVD tests, is expanding its operations and moving to a new location adjacent to CSIRO and the Monash Technology Precinct.

For further information please download the attached PDF: Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?